These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18649402)

  • 41. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
    Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
    Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
    Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M
    J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ABC transporters at the blood-brain barrier.
    Mahringer A; Fricker G
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):499-508. PubMed ID: 26998936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.
    Pottier G; Marie S; Goutal S; Auvity S; Peyronneau MA; Stute S; Boisgard R; Dollé F; Buvat I; Caillé F; Tournier N
    J Nucl Med; 2016 Feb; 57(2):309-14. PubMed ID: 26585058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apical ABC transporters and cancer chemotherapeutic drug disposition.
    Durmus S; Hendrikx JJ; Schinkel AH
    Adv Cancer Res; 2015; 125():1-41. PubMed ID: 25640265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
    Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
    Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ABC Transporters Are Key Players in Alzheimer's Disease.
    Pereira CD; Martins F; Wiltfang J; da Cruz E Silva OAB; Rebelo S
    J Alzheimers Dis; 2018; 61(2):463-485. PubMed ID: 29171999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
    Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
    Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
    Shaik N; Giri N; Pan G; Elmquist WF
    Drug Metab Dispos; 2007 Nov; 35(11):2076-85. PubMed ID: 17709369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.
    Bagal S; Bungay P
    Drug Discov Today Technol; 2014 Jun; 12():e79-85. PubMed ID: 25027378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier.
    Miller DS; Cannon RE
    Curr Pharm Des; 2014; 20(10):1463-71. PubMed ID: 23789954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bringing drugs into the injured brain and keeping them there.
    Hermann DM; Patak P
    Curr Pharm Des; 2011; 17(26):2748-9. PubMed ID: 21827401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.
    Potschka H
    Pharmacol Ther; 2010 Jan; 125(1):118-27. PubMed ID: 19896502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
    Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
    Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Host factors and efficacy of antiretroviral treatment.
    Turriziani O; Antonelli G
    New Microbiol; 2004 Apr; 27(2 Suppl 1):63-9. PubMed ID: 15646066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues.
    Lin F; Marchetti S; Pluim D; Iusuf D; Mazzanti R; Schellens JH; Beijnen JH; van Tellingen O
    Clin Cancer Res; 2013 Apr; 19(8):2084-95. PubMed ID: 23461902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
    Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
    Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.
    Nair M; Jayant RD; Kaushik A; Sagar V
    Adv Drug Deliv Rev; 2016 Aug; 103():202-217. PubMed ID: 26944096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.